Author: Prendecki, Maria; Willicombe, Michelle; McAdoo, Stephen P.
Title: COVID-19 vaccination in patients with immunity-mediated kidney disease Cord-id: rgd5gky1 Document date: 2021_10_19
ID: rgd5gky1
Snippet: Vaccination against SARS-CoV-2 seems to be safe in patients with immunity-mediated kidney disease, although their immunological responses to vaccination are impaired. Further strategies, including the administration of additional vaccine doses and passive immunization with long-acting monoclonal antibodies, might increase protection in this vulnerable patient group.
Document: Vaccination against SARS-CoV-2 seems to be safe in patients with immunity-mediated kidney disease, although their immunological responses to vaccination are impaired. Further strategies, including the administration of additional vaccine doses and passive immunization with long-acting monoclonal antibodies, might increase protection in this vulnerable patient group.
Search related documents:
Co phrase search for related documents- additional vaccine and adenoviral vector vaccine: 1
Co phrase search for related documents, hyperlinks ordered by date